Posts by Admin BioAlps

Development of national secure platforms, leading open science databases & software tools    The Swiss Institute of Bioinformatics (SIB)’s mission, as per its mandate from the Secretariat for Education, Research and Innovation (SERI), is to be a provider of long-term, high-impact infrastructure for the life sciences and the biomedical world. Its teams thus develop national…

Multiplex miCAR™ Technology   Allogene Therapeutics, a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and Antion Biosciences, a Swiss cell and gene engineering company, announced that they have entered into an exclusive collaboration and global license agreement for Antion’s miRNA technology (miCAR™) to advance multiplex gene silencing…

CHF 1.8M to start clinical trials & product industrialisation   Adiposs SA, the developer of a unique diagnostic product for the non-invasive early detection of body wasting-cachexia, announced a CHF 1.8M first closing of its Pre-Series A round. The round was led by Privilège Ventures, a Swiss-based venture capital firm focused on seed and early-stage…

89 new innovative projects in 2022   Venture Kick continues its success story and increases its budget: having supported 841 spin-offs from Swiss universities with CHF 39.71 million in seed capital since 2007, Venture Kick increases the 2022 budget by 10% to CHF 6.1 million. This will allow Venture Kick to provide funds to 89…

Magali Bischof promoted Secretary General of the BioAlps Association   The Executive Committee of the BioAlps Association has chosen Mrs Magali Bischof as the next Secretary General. She will take up her position on 1 January 2022.   BioAlps is celebrating its 20th anniversary supporting Life Sciences innovation in Western Switzerland. The Association builds bridges…

1st closing new financing round with Swiss & international investors   Xsensio, a Lausanne based startup seeking to address the emerging field of wearable biosensing, has successfully completed a first close of its new financing round with Swiss and international investors to address the fast-growing market of wearable biosensing. Xsensio develops the unique Lab-on-Skin sensing…

In November 2021, Intellias, a technology partner of Fortune 500 companies and top-tier organizations, and D36.ch, an innovative Swiss healthcare startup, announced their strategic partnership. The companies are joining efforts to build a bridge between the Swiss digital health market and world-class IT services to reinforce customers’ digital strength by combining 360-degree domain expertise with state-of-the-art software engineering solutions.

Biopôle SA’s innovative life sciences community continues to grow with the addition of Swiss Medical Network, one of Switzerland’s leading private clinic groups. This new partnership will enable Swiss Medical Network to remain at the forefront of medical technology, delivering the highest-quality care to patients from Switzerland and beyond. Operating across all Switzerland, Swiss Medical Network…

1st establishment of a US company in Western Switzerland without prior in-person meeting   A first for the canton of Fribourg (Switzerland) and presumably for Switzerland: in the midst of the pandemic, San Diego, California-based company Sun Genomics established a subsidiary in Fribourg without prior site visits. This settlement was “virtually” completed because of the…

Medical innovation & contribution to the future of medicine   On 30 November, 2021, Mrs Annick Chevillot (Heidi.news) has moderated the BioAlps Netwoking Day (BND) 2021, the annual gathering of Western Switzerland’s Life Sciences’ Community. The BND 2021 focused on the strengths and innovation in the BioAlps’ community and its ability to grow and develop…